Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Róisín-Ana Ní Chárthaigh"'
Autor:
Ritobrata Ghose, Álvaro Aranguren-Ibáñez, Niccolò Arecco, Diego Balboa, Marc Bataller, Sergi Beltran, Hannah Benisty, Angèle Bénard, Edgar Bernardo, Sílvia Carbonell Sala, Eloi Casals, Ludovica Ciampi, Livia Condemi, Alberto Corvó, Marta Cosín-Tomás, Mirabai Cuenca-Ardura, Juan Manuel Duran Serrano, María Isabel Espejo Díaz, Marcos Fernandez Callejo, Antoni Gañez-Zapater, Raquel Garcia-Castellanos, Romina Garrido, Gil Henkin, Toni Hermoso Pulido, Xavier Hernandez-Alias, Jorge Herrero Vicente, Matthew Ingham, Wei Ming Lim, Sílvia Llonch, Elena Marmesat Bertoli, Irene Miguel-Escalada, Ariadna Montero-Blay, Cristina Navarrete Hernández, Maria Victoria Neguembor, Róisín-Ana Ní Chárthaigh, Natalia Pardo-Lorente, Laura Pascual-Reguant, Sílvia Pérez-Lluch, Reyes Perza, Martina Pesaresi, Daniel Picó Amador, Paula Pifarré, Davide Piscia, Marcos Plana-Carmona, Julia Ponomarenko, Leandro Radusky, Ezequiel Rivero, Malgorzata Rogalska, Guillem Torcal Garcia, José Wojnacki
Publikováno v:
F1000Research, Vol 9 (2020)
The COVID-19 pandemic has posed and is continuously posing enormous societal and health challenges worldwide. The research community has mobilized to develop novel projects to find a cure or a vaccine, as well as to contribute to mass testing, which
Externí odkaz:
https://doaj.org/article/a31f23efbb70401e91a65643d3267f89
Autor:
Hannes VoSSfeldt, Malte Butzlaff, Katja PrüSSing, Róisín-Ana Ní Chárthaigh, Peter Karsten, Anne Lankes, Sabine Hamm, Mikael Simons, Boris Adryan, Jörg B Schulz, Aaron Voigt
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e47452 (2012)
Polyglutamine (polyQ) diseases represent a neuropathologically heterogeneous group of disorders. The common theme of these disorders is an elongated polyQ tract in otherwise unrelated proteins. So far, only symptomatic treatment can be applied to pat
Externí odkaz:
https://doaj.org/article/ee4937c7f1d44700bd44afb6b98b0353
Autor:
Alexandre Dubrac, Laurence Pibouin-Fragner, Gael Genet, Róisín-Ana Ní Chárthaigh, Thomas Mathivet, Anne Eichmann, Le Ma, Alain Chédotal, Nicolas Rama, Brunella Cristofaro
Publikováno v:
Scopus-Elsevier
Ocular neovascular diseases are a leading cause of blindness. Vascular endothelial growth factor (VEGF) blockade improves vision, but not all individuals respond to anti-VEGF treatment, making additional means to prevent neovascularization necessary.
Autor:
Boris Adryan, Katja Prüßing, Mikael Simons, Sabine Hamm, Jörg B. Schulz, Róisín-Ana Ní Chárthaigh, Peter Karsten, Malte Butzlaff, Anne Lankes, Aaron Voigt, Hannes Voßfeldt
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 11, p e47452 (2012)
PLOS ONE 7(11), e47452 (2012). doi:10.1371/journal.pone.0047452
PLoS ONE, Vol 7, Iss 11, p e47452 (2012)
PLOS ONE 7(11), e47452 (2012). doi:10.1371/journal.pone.0047452
Polyglutamine (polyQ) diseases represent a neuropathologically heterogeneous group of disorders. The common theme of these disorders is an elongated polyQ tract in otherwise unrelated proteins. So far, only symptomatic treatment can be applied to pat